Commentary
Interpreting the Enhance Trial
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications
Michael H. Davidson, MD
Cleveland Clinic Journal of Medicine July 2008, 75 (7) 479-491;
Michael H. Davidson
Clinical Professor, Director of Preventive Cardiology, The University of Chicago Pritzker School of Medicine
In this issue
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 7
1 Jul 2008
Interpreting the Enhance Trial
Michael H. Davidson
Cleveland Clinic Journal of Medicine Jul 2008, 75 (7) 479-491;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.